As of August 04, 2026, Adial Pharmaceuticals's top three insider holders are William B. Iii Stilley (Chief Executive Officer, 50.47K shares), Cary J Claiborne (Chief Executive Officer, 40.42K shares), Tony Goodman (Chief Operating Officer, 26.52K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Cary J Claiborne | Chief Executive Officer | 40,417 | 0 | 09 Apr, 2026 |
| Tony Goodman | Chief Operating Officer | 26,523 | 0 | 09 Apr, 2026 |
| William B. Iii Stilley | Chief Executive Officer | 50,471 | 0 | 25 May, 2023 |
| Joseph Truluck | Chief Financial Officer | 10,606 | 0 | 25 May, 2023 |
| Kevin Schuyler | - | 9,213 | 0 | 09 Apr, 2026 |
| Bankole A. Johnson | Chief Medical Officer | 0 | 5,930 | 06 Oct, 2021 |
| Robertson H. Gilliland | - | 9,185 | 0 | 09 Apr, 2026 |
| James W. Jr. Newman | - | 800 | 4,774 | 03 Jan, 2022 |
| Vinay Shah | Chief Financial Officer | 17,325 | 0 | 09 Apr, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 07 Apr, 2026 | Robertson H. Gilliland | Common Stock | A | 9,185 | $0.00 | 9,185 | D | A |
| 07 Apr, 2026 | Tony Goodman | Common Stock | A | 26,510 | $0.00 | 26,523 | D | A |
| 07 Apr, 2026 | J. Kermit Anderson | Stock Option (Right to Buy) | A | 9,185 | $0.00 | 9,185 | D | A |
| 07 Apr, 2026 | Robertson H. Gilliland | Common Stock | A | 9,185 | $0.00 | 9,185 | D | A |
| 07 Apr, 2026 | Tony Goodman | Common Stock | A | 26,510 | $0.00 | 26,523 | D | A |
| 07 Apr, 2026 | Tony Goodman | Common Stock | A | 26,510 | $0.00 | 26,523 | D | A |
| 07 Apr, 2026 | Vinay Shah | Common Stock | A | 17,325 | $0.00 | 17,325 | D | A |
| 07 Apr, 2026 | Cary J Claiborne | Common Stock | A | 37,985 | $0.00 | 40,417 | D | A |
| 07 Apr, 2026 | J. Kermit Anderson | Stock Option (Right to Buy) | A | 9,185 | $0.00 | 9,185 | D | A |
| 07 Apr, 2026 | Robertson H. Gilliland | Common Stock | A | 9,185 | $0.00 | 9,185 | D | A |
| 07 Apr, 2026 | Kevin Schuyler | Common Stock | A | 9,185 | $0.00 | 9,213 | D | A |
| 07 Apr, 2026 | J. Kermit Anderson | Stock Option (Right to Buy) | A | 9,185 | $0.00 | 9,185 | D | A |
| 29 May, 2025 | James W. Jr. Newman | Stock Option (Right to Buy) | A | 28,000 | $0.00 | 1,120 | D | A |
| 29 May, 2025 | J. Kermit Anderson | Stock Option (Right to Buy) | A | 28,000 | $0.00 | 1,120 | D | A |
| 29 May, 2025 | Tony Goodman | Stock Option (Right to Buy) | A | 94,000 | $0.00 | 3,760 | D | A |
| 29 May, 2025 | Robertson H. Gilliland | Stock Option (Right to Buy) | A | 28,000 | $0.00 | 1,120 | D | A |
| 29 May, 2025 | J. Kermit Anderson | Stock Option (Right to Buy) | A | 28,000 | $0.00 | 1,120 | D | A |
| 29 May, 2025 | Robertson H. Gilliland | Stock Option (Right to Buy) | A | 28,000 | $0.00 | 1,120 | D | A |
| 29 May, 2025 | Robertson H. Gilliland | Stock Option (Right to Buy) | A | 28,000 | $0.00 | 1,120 | D | A |
| 29 May, 2025 | James W. Jr. Newman | Stock Option (Right to Buy) | A | 28,000 | $0.00 | 1,120 | D | A |